News

The “Korean New Deal” Put Hanmi Pharm Group’s Six Visions- “Cydio Cigma” Under the Spotlight

2020.07.16

On the 14th of this month, the government announced the "Korean New Deal" with a total investment of 160 trillion won by 2025, while the six visions "Cydio Cigma" launched by Hanmi Pharm Group a month ago attracted much attention. This is largely because this idea is perfectly consistent with the main core keywords of Hanmi Pharm Group, such as non-face-to-face, digital, and green.

“Digital New Deal” and “Green New Deal” of the Korean New Deal are also the key elements in the six visions of Hanmi Science, the holding company of Hanmi Pharm. Experts from Hanmi Science said: "As the Korean New Deal has been strongly promoted by the South Korean President, it is injecting policy momentum into the group's future vision." This is a growth momentum plan that reflects the government's strong will to deal with the "post-coronavirus era". From this point of view, the future development trend of Hanmi Science will undoubtedly receive much attention.

"Cydio Sigma" of Hanmi Science is a concept put forward by the Lim Chong-yoon, the CEO of Hanmi Science, who combined the English initials of the six visions. It refers to Cyber Education, Digital Bio, Oral Bio, City Bio, Green Bio, Marine Bio, etc.

Hanmi Science said that it has been innovating in the digital new deal (digital, cyber, AI) proposed by the government. Now the company is operating a smart plant capable of producing 6 billion tablets a year by integrating information and communication technology (RFID, etc.) with big data, and is developing next-generation innovative medical infrastructure systems such as electronic distribution network management system and unmanned prescription system.

As the subsidiary company, Hanmi Pharm is also collaborating with Stamdig, an AI-based new drug development company, to discover innovative new drug candidates. On-line farm, another affiliate, is using a non-face-to-face automatic prescription filing system “Onkiosk” in national pharmacies. At the same time, Hanmi Science also stressed that JVM, which has the technology for an automated pharmacy dispensing and management system, will lead the fourth industrial revolution in the field of automatic dispensing as a subsidiary of Hanmi Science.

In addition, “Eavidnet” a big data specialist invested by Hanmi Science, has the technology to produce big data by safely unifying medical information generated by medical institutions around the world without invading personal information. As COVID-19 spread across the world, the COVID-19 standard data constructed by Eavidnet was shared in a research marathon held by the Global Medical Big Data Consortium. More than 350 researchers from more than 30 countries around the world, including the National Institute of Health (NIH), Johns Hopkins University and Oxford University, took part in the research marathon. It is worth mentioning that the data was sponsored by the Bill and Melinda Gates Foundation, which makes it more meaningful.

The second axis of the Korean New Deal, “Green New Deal,” also shares the same “Green Bio” as suggested by Hanmi Science. Hanmi Science is working with the potential bio-venture company "BioApp" to develop plant-based vaccines. Since the vaccine through green bio does not utilize eggs or animal cells, it is expected that it can solve various problems arising from large-scale facilities in the existing carbon emission process. In particular, Hanmi Science explained that "Green Bio" is capable of mass-producing vaccines in a relatively short period of time without the fear of environmental pollution in the "pandemic outbreak". In fact, egg-based vaccines take about six months to produce, while plant-based vaccines only take about one month (4 to 6 weeks).

It is predicted that if seasonal influenza overlaps with coronavirus pneumonia, it will be difficult to ensure that vaccine production meets the demand. Therefore, it is urgent to establish a professional GMP facility with a green biological basic process system in South Korea.

In line with the government's Korean New Deal, Hanmi Science plans to lay various business foundations to realize the six visions previously announced.

Hanmi Science said: "We welcome the government's announcement of the Korean New Deal that focuses on nurturing the green and digital sectors. Hanmi Science Pharm Group will also do its best to achieve common development in the fourth industrial field of green and innovative digitalization."

Source: Dong-A Ilbo